secwatch.observer — SEC 8-K summary
======================================

Issuer:     Greenbrook TMS Inc. (—)
CIK:        0001735948
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001104659-24-052141
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Greenbrook TMS FY 2023 revenue up 10% to $73.8M; net loss narrows to $49.3M
---------------------------------------------------------------------------

- Revenue $73.8M, +10% YoY; regional operating loss improved 56% to $2.7M.
- Net loss $49.3M vs $88.3M; loss per share $1.25 diluted (prior $3.77).
- Restructuring: closed 53 centers, achieved $23M annual cost savings target, $1M charges.
- Expanded Spravato to 82 centers; launched medication management pilot at 9 centers.
- Company changed to domestic issuer; restated quarterly financials from IFRS to US GAAP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1735948/000110465924052141/0001104659-24-052141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1735948/000110465924052141/tm2411514d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-052141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer